In the latest in a series of recent cases involving the “but-for” causation standard for Anti-Kickback Statute (“AKS”) claims, Judge Waverly D. Crenshaw in the U.S. District Court for the Middle ...
September 25, 2025 - Participants in the health care and life sciences industry continue to face robust False Claims Act ("FCA") enforcement scrutiny and litigation risk. Indeed, on July 2, 2025, the ...
TrumpRx is officially launched, and the jury is still out on whether the platform will do much to decrease healthcare costs for most U.S. patients. But as more pharma companies partner with TrumpRx or ...
In the spring of 2025, two federal courts issued decisions interpreting the federal Anti-Kickback Statute, with one court narrowing the conduct that is prohibited while the other court refused to do ...
Craig Bleifer, Jessica Vaughn, Ph.D. In advance of the anticipated rollout of the “TrumpRx” website, a platform promising lower-priced drugs sold directly to consumers, the Office of Inspector General ...
ASCs continue to face complex regulatory scrutiny under federal anti-kickback and fraud laws, even as they operate outside certain Stark law restrictions. A recent Minnesota Lawyer article and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results